DAI-ICHI KAR | TATVA CHINTAN PHARMA | DAI-ICHI KAR/ TATVA CHINTAN PHARMA |
|||
---|---|---|---|---|---|
P/E (TTM) | x | 39.0 | 77.0 | 50.6% | View Chart |
P/BV | x | 2.8 | 5.6 | 48.9% | View Chart |
Dividend Yield | % | 0.6 | 0.2 | 394.4% |
DAI-ICHI KAR TATVA CHINTAN PHARMA |
EQUITY SHARE DATA | |||||
---|---|---|---|---|---|
DAI-ICHI KAR Mar-23 |
TATVA CHINTAN PHARMA Mar-23 |
DAI-ICHI KAR/ TATVA CHINTAN PHARMA |
5-Yr Chart Click to enlarge
|
||
High | Rs | 448 | 2,649 | 16.9% | |
Low | Rs | 255 | 1,606 | 15.9% | |
Sales per share (Unadj.) | Rs | 246.9 | 191.1 | 129.2% | |
Earnings per share (Unadj.) | Rs | 24.8 | 20.5 | 120.8% | |
Cash flow per share (Unadj.) | Rs | 34.8 | 24.8 | 140.1% | |
Dividends per share (Unadj.) | Rs | 4.00 | 2.00 | 200.0% | |
Avg Dividend yield | % | 1.1 | 0.1 | 1,210.6% | |
Book value per share (Unadj.) | Rs | 228.1 | 232.2 | 98.2% | |
Shares outstanding (eoy) | m | 7.45 | 22.17 | 33.6% | |
Bonus / Rights / Conversions | 0 | 0 | - | ||
Price / Sales ratio | x | 1.4 | 11.1 | 12.8% | |
Avg P/E ratio | x | 14.2 | 103.7 | 13.7% | |
P/CF ratio (eoy) | x | 10.1 | 85.7 | 11.8% | |
Price / Book Value ratio | x | 1.5 | 9.2 | 16.8% | |
Dividend payout | % | 16.1 | 9.7 | 165.6% | |
Avg Mkt Cap | Rs m | 2,619 | 47,157 | 5.6% | |
No. of employees | `000 | NA | NA | - | |
Total wages/salary | Rs m | 157 | 386 | 40.6% | |
Avg. sales/employee | Rs Th | 0 | 0 | - | |
Avg. wages/employee | Rs Th | 0 | 0 | - | |
Avg. net profit/employee | Rs Th | 0 | 0 | - |
INCOME DATA | |||||
---|---|---|---|---|---|
Net Sales | Rs m | 1,839 | 4,236 | 43.4% | |
Other income | Rs m | 64 | 57 | 112.1% | |
Total revenues | Rs m | 1,904 | 4,294 | 44.3% | |
Gross profit | Rs m | 262 | 572 | 45.7% | |
Depreciation | Rs m | 75 | 96 | 78.0% | |
Interest | Rs m | 30 | 86 | 35.3% | |
Profit before tax | Rs m | 221 | 448 | 49.4% | |
Minority Interest | Rs m | 0 | 0 | - | |
Prior Period Items | Rs m | 0 | 0 | - | |
Extraordinary Inc (Exp) | Rs m | 0 | 0 | - | |
Tax | Rs m | 36 | -7 | -514.1% | |
Profit after tax | Rs m | 185 | 455 | 40.6% | |
Gross profit margin | % | 14.2 | 13.5 | 105.3% | |
Effective tax rate | % | 16.5 | -1.6 | -1,041.2% | |
Net profit margin | % | 10.0 | 10.7 | 93.5% |
BALANCE SHEET DATA | |||||
---|---|---|---|---|---|
Current assets | Rs m | 685 | 3,136 | 21.8% | |
Current liabilities | Rs m | 577 | 2,361 | 24.4% | |
Net working cap to sales | % | 5.8 | 18.3 | 32.0% | |
Current ratio | x | 1.2 | 1.3 | 89.3% | |
Inventory Days | Days | 117 | 3 | 3,985.8% | |
Debtors Days | Days | 530 | 73 | 729.1% | |
Net fixed assets | Rs m | 1,984 | 4,304 | 46.1% | |
Share capital | Rs m | 75 | 222 | 33.6% | |
"Free" reserves | Rs m | 1,625 | 4,926 | 33.0% | |
Net worth | Rs m | 1,699 | 5,148 | 33.0% | |
Long term debt | Rs m | 173 | 42 | 407.8% | |
Total assets | Rs m | 2,668 | 7,439 | 35.9% | |
Interest coverage | x | 8.3 | 6.2 | 133.3% | |
Debt to equity ratio | x | 0.1 | 0 | 1,235.6% | |
Sales to assets ratio | x | 0.7 | 0.6 | 121.1% | |
Return on assets | % | 8.1 | 7.3 | 110.9% | |
Return on equity | % | 10.9 | 8.8 | 123.0% | |
Return on capital | % | 13.4 | 10.3 | 130.7% | |
Exports to sales | % | 51.2 | 76.2 | 67.2% | |
Imports to sales | % | 15.0 | 56.9 | 26.3% | |
Exports (fob) | Rs m | 942 | 3,229 | 29.2% | |
Imports (cif) | Rs m | 275 | 2,409 | 11.4% | |
Fx inflow | Rs m | 942 | 3,229 | 29.2% | |
Fx outflow | Rs m | 275 | 2,409 | 11.4% | |
Net fx | Rs m | 667 | 820 | 81.3% |
CASH FLOW | |||||
---|---|---|---|---|---|
From Operations | Rs m | 232 | 278 | 83.5% | |
From Investments | Rs m | -326 | -1,011 | 32.2% | |
From Financial Activity | Rs m | 135 | 378 | 35.6% | |
Net Cashflow | Rs m | 39 | -357 | -10.9% |
Indian Promoters | % | 63.9 | 72.0 | 88.7% | |
Foreign collaborators | % | 0.0 | 0.0 | - | |
Indian inst/Mut Fund | % | 0.0 | 16.5 | - | |
FIIs | % | 0.0 | 3.7 | - | |
ADR/GDR | % | 0.0 | 0.0 | - | |
Free float | % | 36.1 | 28.0 | 129.1% | |
Shareholders | 5,085 | 73,730 | 6.9% | ||
Pledged promoter(s) holding | % | 0.0 | 0.0 | - |
Compare DAI-ICHI KAR With: PIDILITE INDUSTRIES SRF BALAJI AMINES YASHO INDUSTRIES GHCL
No comparison is complete without understanding how the stock prices have performed over a period of time.
Here's a brief comparison:
Period | DAI-ICHI KAR | TATVA CHINTAN PHARMA |
---|---|---|
1-Day | -1.43% | 0.02% |
1-Month | 22.98% | 9.97% |
1-Year | 59.28% | -23.68% |
3-Year CAGR | 20.16% | -18.73% |
5-Year CAGR | 22.69% | -11.70% |
* Compound Annual Growth Rate
Here are more details on the DAI-ICHI KAR share price and the TATVA CHINTAN PHARMA share price.
Moving on to shareholding structures...
The promoters of DAI-ICHI KAR hold a 63.9% stake in the company. In case of TATVA CHINTAN PHARMA the stake stands at 72.0%.
To review how promoter stakes have changed over time, and how much of the promoter stake is pledged, please see the shareholding pattern of DAI-ICHI KAR and the shareholding pattern of TATVA CHINTAN PHARMA.
Finally, a word on dividends...
In the most recent financial year, DAI-ICHI KAR paid a dividend of Rs 4.0 per share. This amounted to a Dividend Payout ratio of 16.1%.
TATVA CHINTAN PHARMA paid Rs 2.0, and its dividend payout ratio stood at 9.7%.
You may visit here to review the dividend history of DAI-ICHI KAR, and the dividend history of TATVA CHINTAN PHARMA.
After opening the day on high, Indian share markets reversed the trend as the session progressed and ended the lower.